Saha Arindam, Hammond Charles E, Trojanowska Maria, Smolka Adam J
Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G795-807. doi: 10.1152/ajpgi.00431.2007. Epub 2008 Jan 17.
Infection of human gastric body mucosa by the gram-negative, microaerophilic bacterium Helicobacter pylori induces an inflammatory response and a transitory hypochlorhydria that progresses in approximately 2% of patients to atrophic gastritis, dysplasia, and gastric adenocarcinoma. We have previously shown that H. pylori infection of cultured gastric epithelial cells (AGS) represses the activity of the transfected alpha-subunit (HKalpha) promoter of H,K-ATPase, the parietal cell enzyme mediating acid secretion. However, the mechanistic details of H. pylori-mediated repression of HKalpha and ensuing hypochlorhydria are unknown. H. pylori is known to upregulate the transcription factor NF-kappaB through the ERK1/2 MAPK pathway. We identified NF-kappaB-binding regions in the HKalpha promoter and found that H. pylori inoculation of AGS cells increased NF-kappaB p50 binding to the transfected HKalpha promoter and repressed its transcriptional activity. Immunoblot and DNA-protein interaction studies showed that although active phosphorylated NF-kappaB p65 is present in H. pylori-infected AGS cells, an NF-kappaB p50/p65 heterodimeric complex fails to bind to the HKalpha promoter. Point mutations at -159 and -161 bp in the HKalpha promoter NF-kappaB binding sequence prevented binding of NF-kappaB p50 and prevented H. pylori repression of point-mutated HKalpha promoter activity in transfected AGS cells. Small interfering RNA-mediated knockdown of NF-kappaB p50 in H. pylori-infected AGS cells also abrogated H. pylori-induced HKalpha repression, whereas NF-kappaB p65 knockdown did not. We conclude that H. pylori inhibits HKalpha gene expression by ERK1/2-mediated NF-kappaB p50 homodimer binding to the HKalpha promoter. This study identifies a novel pathogen-dependent mechanism of H,K-ATPase inhibition and contributes to understanding of H. pylori pathophysiology.
革兰氏阴性微需氧菌幽门螺杆菌感染人体胃体黏膜会引发炎症反应和短暂性胃酸过少,约2%的患者会进展为萎缩性胃炎、发育异常和胃腺癌。我们之前已表明,幽门螺杆菌感染培养的胃上皮细胞(AGS)会抑制转染的壁细胞中介导胃酸分泌的酶H,K-ATP酶α亚基(HKα)启动子的活性。然而,幽门螺杆菌介导的HKα抑制及随之而来的胃酸过少的机制细节尚不清楚。已知幽门螺杆菌通过ERK1/2丝裂原活化蛋白激酶途径上调转录因子核因子κB(NF-κB)。我们在HKα启动子中鉴定出NF-κB结合区域,发现用幽门螺杆菌接种AGS细胞会增加NF-κB p50与转染的HKα启动子的结合,并抑制其转录活性。免疫印迹和DNA-蛋白质相互作用研究表明,尽管在幽门螺杆菌感染的AGS细胞中存在活性磷酸化的NF-κB p65,但NF-κB p50/p65异二聚体复合物无法与HKα启动子结合。HKα启动子NF-κB结合序列中-159和-161 bp处的点突变阻止了NF-κB p50的结合,并阻止了幽门螺杆菌对转染的AGS细胞中HKα启动子活性的点突变抑制。在幽门螺杆菌感染的AGS细胞中,小干扰RNA介导的NF-κB p50敲低也消除了幽门螺杆菌诱导的HKα抑制,而NF-κB p65敲低则没有。我们得出结论,幽门螺杆菌通过ERK1/2介导的NF-κB p50同二聚体与HKα启动子结合来抑制HKα基因表达。本研究确定了一种新的病原体依赖性H,K-ATP酶抑制机制,有助于理解幽门螺杆菌的病理生理学。